1.
The 2010s in clinical drug-eluting stent and bioresorbable scaffold research: a Dutch perspective
2.
3.
4.
2925Four-year clinical outcome following randomised use of zotarolimus-eluting stents versus everolimus-eluting stents in all-comers: insights from the DUTCH PEERS trial